JPMorgan Chase 13F: Cuts Astera Labs (ALAB) Stake by $135M

JPMorgan Chase reduced its investment in Astera Labs, Inc. (ALAB) by 38.8% during the most recent reporting period. According to a Form 13F filing with the SEC, the firm sold 273,080 shares, leaving it with a remaining stake of 430,389 shares. The total value of the holding at the time of the filing was approximately $212.8 million.

Changes in the JPMorgan Chase Position

Before this latest reduction, JPMorgan Chase held 703,469 shares of the semiconductor specialist. The 38.8% cut brings the position down to 430,389 shares. This move follows a string of adjustments by other major institutions earlier in May. While firms like Tudor Investment and Voya Investment Management also pared back their stakes, others like the Swiss National Bank and UBS Am recently added to their holdings. It is worth noting that these 13F filings show what a fund held at the end of the quarter and might not reflect what they own today.

Astera Labs Stock Performance

On Wednesday, shares of Astera Labs were trading at $494.40. The stock has seen incredible momentum lately, trading well above its 50-day moving average of $316.57 and its 200-day moving average of $248.58. The current price is sitting just below the 52-week high of $499.47, a sharp climb from the 52-week low of $97.89. With a market value of $52.39 billion, the company has a price-to-earnings (P/E) ratio of 148.76, though that number drops to a forward P/E of 47.16 when looking at future profit estimates.

Financial Results and Growth

Astera Labs has shown strong financial growth, with revenue reaching $1.20 billion. The company's revenue growth rate stands at 104.5%, showing it is expanding quickly in the AI infrastructure space. It maintains a healthy balance sheet with a current ratio of 10.05, which measures its ability to cover short-term debts. The company is profitable, posting earnings per share of $2.03 and a return on equity of 25.8%. The next big update for the company is expected when it reports earnings again on November 3, 2026.

Insider Buying and Selling at Astera Labs, Inc.

In terms of internal activity, director Bethany Mayer sold 686 shares on June 24, 2026. The shares were sold at an average price of $395.04 for a total of $270,998.67. This transaction was part of a pre-set Rule 10b5-1 trading plan.

Wall Street analysts have been busy updating their targets for the stock. On August 17, 2026, Northland Capital Markets upgraded the stock to an Outperform rating with a $350.00 target. Earlier in August, RBC Capital maintained its Outperform rating and set a high target of $500.00, while Evercore ISI Group lifted its target to $452.00. Currently, 22 analysts follow the stock, and the consensus is a buy with an average price target of $391.77.

About Astera Labs

Astera Labs makes semiconductor-based connectivity tools that help data centers and AI systems run faster and more efficiently. Based in San Jose, California, the company sells hardware and software that manage high-speed data for cloud providers and large equipment manufacturers. As AI technology grows, the demand for the high-speed links Astera provides has become a central part of the company's story.

What's Ahead for Astera Labs, Inc.

Investors will likely watch for the November earnings date to see if the company can maintain its high growth rate. While the JPMorgan Chase filing shows a significant reduction, these backward-looking reports are just one piece of the puzzle. Future filings will reveal if the firm continued to trim its stake or if the stock's recent climb toward $500 changed its strategy.